NCT/Study#

NCT04650451 /

BPX603-201A

A Phase 1/2, Open-Label, Multicenter, Non-Randomized, Safety And Activity Study Of HER-Targeted Dual Switch CAR-T Cells (BPX-603) In Subjects With Previously Treated Advanced HER2-Positive Solid Tumors

A Phase 1/2, Open-Label, Multicenter, Non-Randomized, Safety And Activity Study Of HER-Targeted Dual Switch CAR-T Cells (BPX-603) In Subjects With Previously Treated Advanced HER2-Positive Solid Tumors

DISEASE GROUP:
Phase 1
current phase:
Phase I
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: